跳至主要内容
临床试验/ACTRN12616000063415
ACTRN12616000063415终止未知

Does the use of sugammadex for reversal of paralysis reduce postperative pulmonary events when compared with neostigmine following general anaesthesia

orthern Sydney Anaesthetic Research Institute (NSARI)0 个研究点目标入组 30 人开始时间: 2016年1月21日最近更新:

试验速览

阶段
未知
状态
终止
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • patients presenting for non-cardiac surgery
  • planned operative time of over 2 hours
  • plan to be intubated and to receive muscle relaxants for their surgery
  • plan to stay at least one night in hospital

排除标准

  • Previous recruitment to the trial
  • Patient refusal
  • Weight>200kg
  • Planned postoperative intubation and ventilation
  • Hypersensitivity reactions to any of the study drugs
  • Mechanical obstruction of the intestinal or urinary tracts
  • Peritonitis
  • Liver failure with Child-Pugh class B/C
  • Renal failure with either regular peritoneal or haemodialysis or serum creatinine >140mcgmol/

研究者

发起方
orthern Sydney Anaesthetic Research Institute (NSARI)

相似试验